FN1 and lymphoma: Certain cancers express high level of ED-B fibronectin (i.e. lung cancer, melanoma, colon cancer) whereas others seem to increase the ED-B isoform while they acquire a more aggressive phenotype (i.e. lymphoma, prostate cancer, thymoma/thymic carcinoma and thyroid cancer).